Cover Image

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hugo Klempfner, Paul Anderson
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	BJUI Compass
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
by: Yin Zhou, et al.
Published: (2024)

Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
by: Sean Lim, et al.
Published: (2026)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
by: Mohammed Al‐Zubaidi, et al.
Published: (2024)

Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
by: Shugo Yajima, et al.
Published: (2025)

Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
by: Kylie Yen‐Yi Lim, et al.
Published: (2025)

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
by: Serdar Turan, et al.
Published: (2025)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
by: Alison Hiong, et al.
Published: (2025)

Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
by: Rebecca Martin, et al.
Published: (2025)

Patient experience of bladder cancer: A data linkage study
by: Snehadhar Shah, et al.
Published: (2024)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
by: John Lahoud, et al.
Published: (2024)

Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
by: Liwu Guo, et al.
Published: (2024)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
by: Katherina Y. Chen, et al.
Published: (2026)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
by: Liam Mannion, et al.
Published: (2024)

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
by: Yu Ishizuya, et al.
Published: (2026)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
by: Kunal K. Sindhu, et al.
Published: (2024)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
by: Rodolfo Hurle, et al.
Published: (2025)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
by: Abel Tesfai, et al.
Published: (2024)

Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
by: Jacob Hanna, et al.
Published: (2026)

Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
by: Rachel Weng, et al.
Published: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)

Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
by: Chase Peng Yun Ng, et al.
Published: (2025)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
by: Thomas Philip Cahill, et al.
Published: (2024)

Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
by: Makito Miyake, et al.
Published: (2025)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
by: Amandeep Arora, et al.
Published: (2025)

Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re‐staging TURBT and Intravesical Adjuvant Therapy
by: Tarek Ajami, et al.
Published: (2024)

Health utility value of overactive bladder in Japanese older adults
by: Takashi Yoshioka, et al.
Published: (2024)

Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
by: Joshua D. Cabral, et al.
Published: (2026)

Robotic retroperitoneal surgery in a uro‐oncology specialised centre: Translating RPLND expertise from testicular cancer to non‐genitourinary retroperitoneal tumour resection
by: Alberto Costa Silva, et al.
Published: (2026)

Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
by: Sezgin Yeni, et al.
Published: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
by: Lu Yu Kuo, et al.
Published: (2025)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
by: Austin Drysch, et al.
Published: (2025)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
by: Herbert Lepor, et al.
Published: (2025)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
by: Cameron E. Alexander, et al.
Published: (2024)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)

Incidental crossed fused renal ectopia detected during prostate cancer staging: A photorealistic three‐dimensional rendering
by: Kei Ushijima, et al.
Published: (2025)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
by: Stijn M. van den Bosch, et al.
Published: (2026)

Malignant upper urinary tract obstruction in cancer patients: A systematic review
by: Max Shah, et al.
Published: (2024)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
by: Jonathon Dawson, et al.
Published: (2024)